Stocks and Investing
Stocks and Investing
Tue, October 24, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, October 23, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Seamus Fernandez Maintained (AZN) at Hold with Increased Target to $34 on, Oct 23rd, 2017
Seamus Fernandez of Leerink Swann, Maintained "AstraZeneca PLC" (AZN) at Hold with Increased Target from $31 to $34 on, Oct 23rd, 2017.
Seamus has made no other calls on AZN in the last 4 months.
There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, 0 agree with Seamus's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Seamus
- Tim Anderson of "Bernstein" Upgraded from Hold to Buy on, Friday, September 22nd, 2017
- Alex Arfaei of "BMO Capital" Initiated at Buy and Held Target at $38 on, Thursday, September 7th, 2017
Contributing Sources